Literature DB >> 15621283

Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme.

Donato Colangelo1, AnnaLisa Ghiglia, AnnaRita Ghezzi, Mauro Ravera, Edward Rosenberg, Fabrizio Spada, Domenico Osella.   

Abstract

We have studied the ability of several bioorganometallic clusters [(mu-H)Os(3)(CO)(9)(L)(mu(3)-eta(2)-(Q-H))], where L = [P(C(6)H(4)SO(3)Na)(3)] or [P(OCH(2)CH(2)NMe(3)I)(3)], and Q = quinoline, 3-aminoquinoline, quinoxaline or phenanthridine, of inhibiting telomerase, a crucial enzyme for cancer progression. In general, quinolines have shown interesting biological properties, especially in inhibiting enzymes. For example, the 2,3,7-trichloro-5-nitroquinoxaline (TNQX) exhibited strong anti-telomerase activity in vitro. Among the quinoline-clusters under study, only the negatively charged ones (by virtue of the sulfonated phosphines) exhibited good anti-telomerasic activity on semi-purified enzyme in a cell-free assay, while they were ineffective in vitro on Taq, a different DNA-polymerase. On the contrary, the treatment of breast cancer MCF-7 cell line did not evidence any activity of these clusters, suggesting a low aptitude for crossing cell membrane. Furthermore, all clusters exhibited non-specific, acute cytotoxicy, probably due to accumulation on cell membranes by virtue of their amphiphilic character. A detailed study of Os uptake and accumulation in MCF-7 cells supported this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621283     DOI: 10.1016/j.jinorgbio.2004.10.027

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

Review 1.  The impact of cellular senescence in cancer therapy: is it true or not?

Authors:  Yi Zhang; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

2.  Experimental and computational preference for phosphine regioselectivity and stereoselective tripodal rotation in HOs3(CO)8(PPh3)2(μ-1,2-N,C-η11-C7H4NS).

Authors:  Shahin A Begum; Md Arshad H Chowdhury; Shishir Ghosh; Derek A Tocher; Michael G Richmond; Li Yang; K I Hardcastle; Edward Rosenberg; Shariff E Kabir
Journal:  RSC Adv       Date:  2018-09-21       Impact factor: 4.036

Review 3.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.